Cover Image

Tumor mutational burden as a predictive biomarker in solid tumors

Tumor mutational burden (TMB), defined as the number of somatic mutations per megabase of interrogated genomic sequence, varies across malignancies. Panel sequencing-based estimates of TMB have largely replaced whole-exome sequencing-derived TMB in the clinic. Retrospective evidence suggests that TM...

Full description

Saved in:
Bibliographic Details
Main Authors: Sha, Dan (Author) , Jin, Zhaohui (Author) , Budczies, Jan (Author) , Kluck, Klaus (Author) , Stenzinger, Albrecht (Author) , Sinicrope, Frank A. (Author)
Format: Article (Journal)
Language:English
Published: November 2, 2020
In: Cancer discovery
Year: 2020, Volume: 10, Issue: 12, Pages: 1808-1825
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-20-0522
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/2159-8290.CD-20-0522
Verlag, lizenzpflichtig, Volltext: https://cancerdiscovery.aacrjournals.org/content/10/12/1808
Get full text
Author Notes:Dan Sha, Zhaohui Jin, Jan Budczies, Klaus Kluck, Albrecht Stenzinger, and Frank A. Sinicrope

MARC

LEADER 00000caa a2200000 c 4500
001 1747857580
003 DE-627
005 20220819101329.0
007 cr uuu---uuuuu
008 210209s2020 xx |||||o 00| ||eng c
024 7 |a 10.1158/2159-8290.CD-20-0522  |2 doi 
035 |a (DE-627)1747857580 
035 |a (DE-599)KXP1747857580 
035 |a (OCoLC)1341391939 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sha, Dan  |e VerfasserIn  |0 (DE-588)1226798691  |0 (DE-627)174787549X  |4 aut 
245 1 0 |a Tumor mutational burden as a predictive biomarker in solid tumors  |c Dan Sha, Zhaohui Jin, Jan Budczies, Klaus Kluck, Albrecht Stenzinger, and Frank A. Sinicrope 
264 1 |c November 2, 2020 
300 |a 18 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.02.2021 
520 |a Tumor mutational burden (TMB), defined as the number of somatic mutations per megabase of interrogated genomic sequence, varies across malignancies. Panel sequencing-based estimates of TMB have largely replaced whole-exome sequencing-derived TMB in the clinic. Retrospective evidence suggests that TMB can predict the efficacy of immune checkpoint inhibitors, and data from KEYNOTE-158 led to the recent FDA approval of pembrolizumab for the TMB-high tumor subgroup. Unmet needs include prospective validation of TMB cutoffs in relationship to tumor type and patient outcomes. Furthermore, standardization and harmonization of TMB measurement across test platforms are important to the successful implementation of TMB in clinical practice. - Significance: Evaluation of TMB as a predictive biomarker creates the need to harmonize panel-based TMB estimation and standardize its reporting. TMB can improve the predictive accuracy for immunotherapy outcomes, and has the potential to expand the candidate pool of patients for treatment with immune checkpoint inhibitors. 
700 1 |a Jin, Zhaohui  |e VerfasserIn  |4 aut 
700 1 |a Budczies, Jan  |d 1970-  |e VerfasserIn  |0 (DE-588)124086403  |0 (DE-627)706532724  |0 (DE-576)186167679  |4 aut 
700 1 |a Kluck, Klaus  |e VerfasserIn  |0 (DE-588)122679940X  |0 (DE-627)1747876127  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Sinicrope, Frank A.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cancer discovery  |d Philadelphia, Pa. : [Verlag nicht ermittelbar], 2011  |g 10(2020), 12, Seite 1808-1825  |h Online-Ressource  |w (DE-627)659209411  |w (DE-600)2607892-2  |w (DE-576)347274315  |x 2159-8290  |7 nnas  |a Tumor mutational burden as a predictive biomarker in solid tumors 
773 1 8 |g volume:10  |g year:2020  |g number:12  |g pages:1808-1825  |g extent:18  |a Tumor mutational burden as a predictive biomarker in solid tumors 
856 4 0 |u https://doi.org/10.1158/2159-8290.CD-20-0522  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://cancerdiscovery.aacrjournals.org/content/10/12/1808  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210209 
993 |a Article 
994 |a 2020 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 4 
998 |g 122679940X  |a Kluck, Klaus  |m 122679940X:Kluck, Klaus  |d 910000  |d 912000  |e 910000PK122679940X  |e 912000PK122679940X  |k 0/910000/  |k 1/910000/912000/  |p 3 
998 |g 124086403  |a Budczies, Jan  |m 124086403:Budczies, Jan  |d 910000  |d 912000  |e 910000PB124086403  |e 912000PB124086403  |k 0/910000/  |k 1/910000/912000/  |p 2 
999 |a KXP-PPN1747857580  |e 3850180700 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Dan Sha, Zhaohui Jin, Jan Budczies, Klaus Kluck, Albrecht Stenzinger, and Frank A. Sinicrope"]},"title":[{"title":"Tumor mutational burden as a predictive biomarker in solid tumors","title_sort":"Tumor mutational burden as a predictive biomarker in solid tumors"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"659209411","language":["eng"],"note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Tumor mutational burden as a predictive biomarker in solid tumorsCancer discovery","id":{"zdb":["2607892-2"],"issn":["2159-8290"],"eki":["659209411"]},"origin":[{"publisher":"[Verlag nicht ermittelbar]","publisherPlace":"Philadelphia, Pa.","dateIssuedDisp":"[2011]-"}],"part":{"year":"2020","extent":"18","text":"10(2020), 12, Seite 1808-1825","issue":"12","volume":"10","pages":"1808-1825"},"title":[{"title_sort":"Cancer discovery","title":"Cancer discovery"}],"name":{"displayForm":["American Association for Cancer Research"]},"pubHistory":["Volume 1, number 1 (June 2011)-"]}],"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"November 2, 2020"}],"id":{"doi":["10.1158/2159-8290.CD-20-0522"],"eki":["1747857580"]},"person":[{"family":"Sha","given":"Dan","roleDisplay":"VerfasserIn","role":"aut","display":"Sha, Dan"},{"display":"Jin, Zhaohui","roleDisplay":"VerfasserIn","role":"aut","given":"Zhaohui","family":"Jin"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Budczies, Jan","family":"Budczies","given":"Jan"},{"display":"Kluck, Klaus","roleDisplay":"VerfasserIn","role":"aut","given":"Klaus","family":"Kluck"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Stenzinger, Albrecht","family":"Stenzinger","given":"Albrecht"},{"given":"Frank A.","family":"Sinicrope","display":"Sinicrope, Frank A.","role":"aut","roleDisplay":"VerfasserIn"}],"note":["Gesehen am 09.02.2021"],"language":["eng"],"recId":"1747857580","physDesc":[{"extent":"18 S."}]} 
SRT |a SHADANJINZTUMORMUTAT2202 

Similar Items